Steven L. Hoerter serves as Executive at Clovis Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Steven L. Hoerter has executed 62 insider transactions totaling $9.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 23, 2018 involved exercising options for 25,000 shares valued at $994.0K.
Steven L. Hoerter currently holds 40,000 shares of Clovis Oncology, Inc. (CLVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven L. Hoerter has been a net seller of CLVS stock. They have purchased $265.0K and sold $9.4M worth of shares.
Steven L. Hoerter's most recent insider trade was on Jan 23, 2018, when they sold 25,000 shares at $39.76 per share.
Get notified when new Form 4 filings are submitted
| $74.83 |
| Discretionary |
| Mar 5, 2015 | CLVS | $220.4K | Option Exercise | 20,000 | $11.02 | Discretionary |
| Mar 5, 2015 | CLVS | $1.6M | Sale | 20,000 | $80.00 | Discretionary |
| Feb 17, 2015 | CLVS | $110.2K | Option Exercise | 10,000 | $11.02 | Discretionary |
| Feb 17, 2015 | CLVS | $720.0K | Sale | 10,000 | $72.00 | Discretionary |
| Jan 16, 2015 | CLVS | $110.2K | Option Exercise | 10,000 | $11.02 | Discretionary |
| Jan 16, 2015 | CLVS | $670.0K | Sale | 10,000 | $67.00 | Discretionary |
| Jan 13, 2015 | CLVS | $110.2K | Option Exercise | 10,000 | $11.02 | Discretionary |
| Jan 13, 2015 | CLVS | $620.0K | Sale | 10,000 | $62.00 | Discretionary |
| Jun 4, 2013 | CLVS | $110.2K | Option Exercise | 10,000 | $11.02 | Discretionary |
| Jun 4, 2013 | CLVS | $730.6K | Sale | 10,000 | $73.06 | Discretionary |